Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhanced Outcome Prediction in Cutaneous Squamous Cell Carcinoma Using Deep-learning and Computational Histopathology

NCT06327971 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.

NCT NCT06327971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06327971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhanced Outcome Prediction in Cutaneous Squamous Cell Carcinoma Using Deep-learning and Computational Histopathology
Lead sponsor
Queen Mary University of London
Phase
Observational
Overall status
Active, not recruiting
Start date
October 20, 2023
Completion date
October 31, 2028
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

squamous cell carcinoma of the skin